Disability Related to Chronic Graft-versus-Host Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disability Related to Chronic Graft-versus-Host Disease

Published:2020-04 Issue:4 Volume:26 Page:772-777
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Hamilton Betty K.,Storer Barry E.,Wood William A.,Pidala Joseph A.,Cutler Corey S.,Martin Paul J.,Chen George,Flowers Mary E.,Lee Stephanie J.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference28 articles.

1. Disability related to chronic graft-versus-host disease after alternative donor hematopoietic cell transplantation;Fatobene;Haematologica,2019

2. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation;Martin;J Clin Oncol,2010

3. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation;Wingard;J Clin Oncol,2011

4. Recognizing and managing chronic graft-versus-host disease;Lee;Hematology Am Soc Hematol Educ Program,2008

5. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium;Pidala;Blood,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host Disease;Contemporary Clinical Trials;2024-10

2. Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey;Oncology and Therapy;2024-06-25

3. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC;Transplantation;2024-04-30

4. Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation;Transplantation and Cellular Therapy;2023-02

5. Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors;Transplantation and Cellular Therapy;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3